Cargando…

Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era

BACKGROUND: Immunotherapy is currently being examined as a treatment modality for glioblastoma. Maintaining an optimal total lymphocyte count (TLC) after radiotherapy (RT) and using temozolomide may be beneficial in optimizing immunotherapy. However, conventional temozolomide-based chemoradiation is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byun, Hwa Kyung, Kim, Nalee, Yoon, Hong In, Kang, Seok-Gu, Kim, Se Hoon, Cho, Jaeho, Baek, Jong Geol, Chang, Jong Hee, Suh, Chang-Ok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436232/ https://www.ncbi.nlm.nih.gov/pubmed/30917849 http://dx.doi.org/10.1186/s13014-019-1256-6

Ejemplares similares

Lymphopenia during chemoradiation—foe or friend
por: Patil, Vijay M, et al.
Publicado: (2020)

Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle
por: Kim, Kyung Hwan, et al.
Publicado: (2021)

Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma
por: Lee, Changik, et al.
Publicado: (2020)

ATM mutations improve radio-sensitivity in wild-type isocitrate dehydrogenase-associated high-grade glioma: retrospective analysis using next-generation sequencing data
por: Kim, Nalee, et al.
Publicado: (2020)

Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite Controller
por: Reiss, Kim A., et al.
Publicado: (2016)

Artificial Intelligence-based Radiomics in the Era of Immuno-oncology
por: Kang, Cyra Y, et al.
Publicado: (2022)

Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review
por: Najafi, Masoumeh, et al.
Publicado: (2023)

Current markers and their value in the era of immuno-oncology
por: von Rundstedt, Friedrich-Carl, et al.
Publicado: (2017)

Immuno-oncology: are TAM receptors in glioblastoma friends or foes?
por: Zhou, Yunxiang, et al.
Publicado: (2021)

Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
por: Cui, Xiaoteng, et al.
Publicado: (2021)

The hubris and humility of cancer pharmacology in the post immuno‐oncology era
por: Lazo, John S.
Publicado: (2019)

The changing face of clinical trials in the personalized medicine and immuno-oncology era: report from the international congress on clinical trials in Oncology & Hemato-Oncology (ICTO 2017)
por: Golan, Talia, et al.
Publicado: (2017)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer
por: Lee, Shing Fung, et al.
Publicado: (2022)

Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy
por: Skolnik, Aaron D., et al.
Publicado: (2018)

Immuno-Oncology
por: Chaudhuri, Swapna
Publicado: (2017)

Practical aspects of the application of helical tomotherapy for craniospinal irradiation
por: Lee, Joongyo, et al.
Publicado: (2021)

The immuno-oncology framework: Enabling a new era of cancer therapy
por: Hoos, Axel, et al.
Publicado: (2012)

SCLC Treatment in the Immuno-Oncology Era: Current Evidence and Unmet Needs
por: Belluomini, Lorenzo, et al.
Publicado: (2022)

Early hypopharyngeal cancer treated with different therapeutic approaches: a single-institution cohort analysis
por: Kim, Nalee, et al.
Publicado: (2016)

Bringing the Next Generation of Immuno-Oncology Biomarkers to the Clinic
por: Cesano, Alessandra, et al.
Publicado: (2018)

Considerations for the clinical development of immuno-oncology agents in cancer
por: Pandiella, Atanasio, et al.
Publicado: (2023)

Predictive value of interim (18)F-FDG-PET in patients with non-small cell lung cancer treated with definitive radiation therapy
por: Kim, Nalee, et al.
Publicado: (2020)

Rapidly Evolving Landscape and Future Horizons in Hepatocellular Carcinoma in the Era of Immuno-Oncology
por: Kang, Sandra Mirie, et al.
Publicado: (2022)

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018)

Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy
por: Choi, Seo Hee, et al.
Publicado: (2017)

Immuno‐Oncology in China
por: Lu, Shun, et al.
Publicado: (2019)

Radiomics in immuno-oncology
por: Bodalal, Z., et al.
Publicado: (2021)

Immuno-oncology trends: preclinical models, biomarkers, and clinical development
por: Franklin, Maryland Rosenfeld, et al.
Publicado: (2022)

Current and Future Clinical Applications of ctDNA in Immuno-Oncology
por: Stadler, Julia-Christina, et al.
Publicado: (2022)

Challenges associated with the integration of immuno-oncology agents in clinical practice
por: Lazure, Patrice, et al.
Publicado: (2022)

The Role of Radiation Oncology in Immuno‐Oncology
por: Meng, Xiangjiao, et al.
Publicado: (2019)

Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer
por: Lee, Jong Lyul, et al.
Publicado: (2019)

The Roles of Radiotherapy and Chemotherapy in the Era of Multimodal Treatment for Early-Stage Nasal-Type Extranodal Natural Killer/T-Cell Lymphoma
por: Kim, Tae Hyung, et al.
Publicado: (2016)

Optimal Timing of Radiotherapy after Incomplete Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma
por: Byun, Hwa Kyung, et al.
Publicado: (2021)

Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
por: Lee, Dae Ho
Publicado: (2018)

Successful salvage treatment of myxoid liposarcoma with multiple peritoneal seeding using helical tomotherapy-based intraperitoneal radiotherapy: a case report
por: Choi, Chihwan, et al.
Publicado: (2015)

Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity
por: Sheu, Ting-Ting, et al.
Publicado: (2021)

Tumor-Derived Exosomes (TEX) and Their Role in Immuno-Oncology
por: Whiteside, Theresa L., et al.
Publicado: (2021)

Current clinical challenges and opportunities in oncologists' familiarity and understanding of immuno-oncology
por: Herrmann, Tara, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_53egh2ug3jttrmtld7lc72muoh